Skip to main content

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Light Treatment Effectiveness (LITE) Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Light Treatment Effectiveness (LITE) Study

Cardiovalve Transfemoral Mitral Valve System

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Cardiovalve Transfemoral Mitral Valve System

Extension Study in Primary Distal Renal Tubular Acidosis

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Extension Study in Primary Distal Renal Tubular Acidosis

CemiplimAb Survivorship Epidemiology

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about CemiplimAb Survivorship Epidemiology

Analysis of Both Sex and Device Specific Factors on Outcomes in Patients With Non-Ischemic Cardiomyopathy

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Analysis of Both Sex and Device Specific Factors on Outcomes in Patients With Non-Ischemic Cardiomyopathy

Long-term Safety and Efficacy Extension Trial of Bimatoprost SR

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Long-term Safety and Efficacy Extension Trial of Bimatoprost SR

RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer

A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism

Efficacy and Safety of Sugammadex in High-Risk Ambulatory Surgeries

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Efficacy and Safety of Sugammadex in High-Risk Ambulatory Surgeries

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 215
  • Page 216
  • Page 217
  • Page 218
  • Page 219
  • Page 220
  • Page 221
  • Page 222
  • Page 223
  • …
  • Next page Next
  • Last page Last
Subscribe to